Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

ClinicalTrials.gov ID: NCT02965456

Public ClinicalTrials.gov record NCT02965456. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study was to evaluate the efficacy, safety, and tolerability of a once daily topical application of IDP-121 Lotion compared with its vehicle (IDP-121 Vehicle Lotion) in participants with moderate to severe acne vulgaris (acne) (that is, acne having an Evaluator's Global Severity Score \[EGSS\] of 3 \[moderate\] or 4 \[severe\]).

Study identification

NCT ID
NCT02965456
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
820 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 4, 2015 (Actual)
Primary completion
Feb 23, 2017 (Actual)
Completion
Feb 23, 2017 (Actual)
Last update posted
Dec 18, 2019

2015 – 2017

United States locations

U.S. sites
34
U.S. states
16
U.S. cities
30
Facility City State ZIP Site status
Valeant Site 21 Glendale Arizona 85308 —
Valeant Site 34 Rogers Arkansas 72758 —
Valeant Site 25 Anaheim California 92801 —
Valeant Site 18 Beverly Hills California 90210 —
Valeant Site 09 Fremont California 94538 —
Valeant Site 17 Murrieta California 92526 —
Valeant Site 26 Oxnard California 93035 —
Valeant Site 22 Sacramento California 95819 —
Valeant Site 02 San Diego California 92123 —
Valeant Site 04 San Diego California 92123 —
Valeant Site 19 Santa Monica California 90404 —
Valeant Site 15 Miami Florida 33015 —
Valeant Site 11 Miami Florida 33144 —
Valeant Site 27 Pinellas Park Florida 33782 —
Valeant Site 31 Sanford Florida 32771 —
Valeant Site 05 Tampa Florida 33624 —
Valeant Site 28 Marietta Georgia 30060 —
Valeant Site 16 Buffalo Grove Illinois 60089 —
Valeant Site 06 Indianapolis Indiana 46256 —
Valeant Site 12 Overland Park Kansas 66215 —
Valeant Site 32 Crowley Louisiana 70526 —
Valeant Site 30 Clarkston Michigan 48346 —
Valeant Site 03 Detroit Michigan 48302 —
Valeant Site 20 Henderson Nevada 89074 —
Valeant Site 08 New York New York 10016 —
Valeant Site 23 Winston-Salem North Carolina 27104 —
Valeant Site 29 Hazleton Pennsylvania 18201 —
Valeant Site 24 Johnston Rhode Island 02919 —
Valeant Site 10 Austin Texas 78759 —
Valeant Site 01 Houston Texas 77065 —
Valeant Site 33 Port Arthur Texas 77460 —
Valeant Site 07 San Antonio Texas 78229 —
Valeant Site 13 San Antonio Texas 78229 —
Valeant Site 14 San Antonio Texas 78249 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02965456, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2019 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02965456 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →